LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired Fulcrum ...
NEW YORK, June 20, 2023 (GLOBE NEWSWIRE) -- Attention Fulcrum Therapeutics, Inc. ("Fulcrum") FULC shareholders: The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on ...
SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs investors that a shareholder filed a class action on behalf of all persons and entities that purchased Fulcrum Therapeutics, Inc. (NASDAQ: FULC) common ...
SAN DIEGO, May 15, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased Fulcrum Therapeutics, Inc.
Did you lose money on investments in Fulcrum Therapeutics, Inc.? If so, please visit Fulcrum Therapeutics, Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or ...
SAN DIEGO, May 02, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased Fulcrum Therapeutics, Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback